To evaluate whether pre- to postoperative changes in serum levels of EGFR and EGFR ligands might provide prognostic information in early-stage breast cancer patients, we conducted plots depicting the pre- to postoperative changes of each biomarker for the individual patients. Here, EGFR is linked to breast cancer.